Companies/US/HAE

HAEMONETICS CORPORATION

Income flow

Annual
HAE 10-K Income StatementPeriod 2026-03-28Source 10-K
Hospital$588MPlasma$524MBlood Center$221MRevenue$1B-2% Y/YGross profit$788M+5% Y/YCost of revenue$546MOperating profit$157M-29% Y/YOperating expenses$631MNet profit$97M-42% Y/YTax$31MSG&A$442MR&D & other$188M

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Revenue mix

2026-03-28 · 10-K · USD
By activity
By activity$1.3B
  • Hospital$588M44.1%
  • Plasma$524M39.3%
  • Blood Center$221M16.6%
By geography
By geography$1.3B
  • United States$982M73.6%
  • Europe$185M13.9%
  • Asia$87M6.5%
  • JP$68M5.1%
  • Other Countryor Region$11M0.9%

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).0.00%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).0PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.0.0%Shares outTotal shares currently outstanding (issued and not retired).45.5MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).44.9M
Stock splits
  1. 2:12012-12-03

Valuation

Trailing PE 26.4 (2026-03-28)PE trend

Fiscal PE2

PeriodEPSClosePE
2026-03-282.0554.0426.4
2025-03-293.3163.1919.1

PE = stored close ÷ as-filed diluted EPS (annual 10-K / 20-F). Not a vendor PE series.